.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Managing the risk of placenta accreta spectrum transfusion is a critical priority for obstetricians performing cesarean deliveries. Placenta accreta spectrum (PAS) often involves severe hemorrhage, making it a leading cause of maternal morbidity in India. However, specific indicators to predict the need for intraoperative blood products remain scarce in clinical practice. Consequently, researchers conducted a retrospective study to identify which routinely available clinical and sonographic factors correlate with transfusion requirements.
The study analyzed 312 patients and found that 40% required intraoperative blood products. Notably, an antenatal diagnosis of placenta previa and sonographic suspicion of PAS emerged as the strongest independent predictors. Patients with placenta previa faced a nearly five-fold increase in transfusion risk. Moreover, sonographic suspicion more than tripled the odds of needing a transfusion. These findings demonstrate that clinicians can effectively use these markers during preoperative planning to enhance patient safety. Similarly, identifying these factors early allows for better resource allocation in tertiary centers.
In cases of grade-1 PAS, placenta previa remained the primary predictor of transfusion. Furthermore, the researchers observed that intraoperative factors like hysterectomy and longer operative times were more common among transfused patients. However, these factors typically reflect surgical complexity rather than initial preoperative risk. Therefore, utilizing antenatal ultrasound and clinical history is essential for pragmatic surgical preparation. Additionally, a multidisciplinary approach ensures that surgical teams remain prepared for potential hemodynamic instability during delivery.
The primary clinical predictors are an antenatal diagnosis of placenta previa and sonographic suspicion of placenta accreta spectrum. These factors are strongly associated with the increased need for intraoperative blood products.
In grade-1 placenta accreta spectrum, placenta previa acts as the sole independent predictor for blood transfusion. It significantly increases the likelihood of surgical complexity and intraoperative hemorrhage.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study identifies placenta previa and ultrasound suspicion as major predictors for intraoperative blood transfusion in placenta accreta spectrum management...
2 months ago
A comprehensive systematic review reveals that adult patients with systemic lupus erythematosus face a significant stigma burden. Nearly half experience discrimination, which correlates with heightened psychological distress and disease activity, underscoring the need for routine psychosocial screening.
Today
A study in Colombo, Sri Lanka reveals that 39.8% of lifetime pregnancies among female sex workers were unintended. Early entry into sex work and higher parity were key risk correlates, emphasizing the need for outreach pregnancy testing and rapid access to contraception.
Today
A cross-sectional analysis from the Electronic Framingham Heart Study reveals that a higher daily heart rate per step ratio is associated with lower composite cognitive scores in older adults, highlighting smartwatch metrics as valuable tools for detecting subclinical cardiovascular factors linked to brain health.
Today
A cadaveric study compares the biomechanical strength, load-to-failure, and stiffness of tape-augmented all-soft tissue quadriceps tendon autografts against quadrupled semitendinosus constructs in ACL reconstruction, providing crucial insights for orthopaedic surgeons regarding graft selection and fixation.
Today
Preclinical toxicology of an equimolar D-beta-hydroxybutyrate (D-BHB) formulation for long-chain fatty acid oxidation disorders established a minipig NOAEL of 500 mg/kg BID (1000 mg/kg/day). Key acute findings included transient hypertension, tachycardia, QTc prolongation, and diarrhea at high doses.
Today
